Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder

Clinical trial NCT01000493 · COMPLETED

Trial details

NCT number: NCT01000493
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Post-Traumatic Stress Disorder

Start date: 2009-11-02
Primary completion: 2010-06-28
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.